Ambrose Healthcare

Ambrose Healthcare is a UK specialist pharmaceutical company developing treatments for rare diseases and patients in hospital and specialist care settings.

The company builds its pipeline through the acquisition and licensing of late-stage clinical assets with existing human safety and efficacy data, targeting indications with significant unmet need and no approved therapies.

Current pipeline assets address gastrointestinal symptoms in cystic fibrosis and oncology indications including non-small cell lung cancer.